192 related articles for article (PubMed ID: 15031358)
1. Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapy.
Stenvinkel P; Diczfalusy U; Lindholm B; Heimbürger O
Nephrol Dial Transplant; 2004 Apr; 19(4):972-6. PubMed ID: 15031358
[TBL] [Abstract][Full Text] [Related]
2. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
3. Bone mineral density in end-stage renal disease patients: association with wasting, cardiovascular disease and mortality.
Matsubara K; Suliman ME; Qureshi AR; Axelsson J; Martola L; Heimbürger O; Barany P; Stenvinkel P; Lindholm B
Blood Purif; 2008; 26(3):284-90. PubMed ID: 18421213
[TBL] [Abstract][Full Text] [Related]
4. Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus.
Suliman ME; Stenvinkel P; Bárány P; Heimbürger O; Anderstam B; Lindholm B
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S89-95. PubMed ID: 12612961
[TBL] [Abstract][Full Text] [Related]
5. Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease.
Matsubara K; Stenvinkel P; Qureshi AR; Carrero JJ; Axelsson J; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Suliman ME
J Nephrol; 2009; 22(6):774-82. PubMed ID: 19967657
[TBL] [Abstract][Full Text] [Related]
6. The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden.
Evans M; Fryzek JP; Elinder CG; Cohen SS; McLaughlin JK; Nyrén O; Fored CM
Am J Kidney Dis; 2005 Nov; 46(5):863-70. PubMed ID: 16253726
[TBL] [Abstract][Full Text] [Related]
7. A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure. Evidence of increased oxidative stress in malnourished patients.
Stenvinkel P; Holmberg I; Heimbürger O; Diczfalusy U
Nephrol Dial Transplant; 1998 Oct; 13(10):2594-600. PubMed ID: 9794566
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and underlying cardiovascular diseases in incident ESRD patients.
Di Benedetto A; Marcelli D; D'Andrea A; Cice G; D'Isa S; Cappabianca F; Pacchiano G; D'Amato R; Oggero AR; Bonanno D; Pergamo O; Calabrò R
J Nephrol; 2005; 18(5):592-8. PubMed ID: 16299687
[TBL] [Abstract][Full Text] [Related]
9. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease.
Yao Q; Pecoits-Filho R; Lindholm B; Stenvinkel P
Scand J Urol Nephrol; 2004; 38(5):405-16. PubMed ID: 15764253
[TBL] [Abstract][Full Text] [Related]
10. Inflammation and oxidative stress in ESRD--the role of myeloperoxidase.
Maruyama Y; Lindholm B; Stenvinkel P
J Nephrol; 2004; 17 Suppl 8():S72-6. PubMed ID: 15599890
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress in patients with end-stage renal disease prior to the start of renal replacement therapy.
Diepeveen SH; Verhoeven GH; van der Palen J; Dikkeschei BL; van Tits LJ; Kolsters G; Offerman JJ; Bilo HJ; Stalenhoef AF
Nephron Clin Pract; 2004; 98(1):c3-7. PubMed ID: 15361698
[TBL] [Abstract][Full Text] [Related]
12. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology?
Busch M; Fleck C; Wolf G; Stein G
Amino Acids; 2006 May; 30(3):225-32. PubMed ID: 16680555
[TBL] [Abstract][Full Text] [Related]
13. Association between oestrogen receptor alpha gene polymorphism and mortality in female end-stage renal disease patients.
Kato S; Lindholm B; Axelsson J; Qureshi RA; Barany P; Heimbürger O; Gustafsson JA; Stenvinkel P; Nordfors L
Nephrol Dial Transplant; 2007 Sep; 22(9):2571-7. PubMed ID: 17452407
[TBL] [Abstract][Full Text] [Related]
14. Effects of low- and high-flux dialyzers on oxidative stress and insulin resistance.
Chu PL; Chiu YL; Lin JW; Chen SI; Wu KD
Blood Purif; 2008; 26(2):213-20. PubMed ID: 18285698
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of troponin T and homocysteine in patients with end-stage renal disease.
Sahinarslan A; Güz G; Okyay K; Mutluay R; Yalçin R; Bali M; Sindel S; Cengel A
Turk Kardiyol Dern Ars; 2008 Sep; 36(6):382-7. PubMed ID: 19155641
[TBL] [Abstract][Full Text] [Related]
16. [Cardiovascular risk in patients with chronic renal failure. Patients in renal replacement therapy].
Cases A; Vera M; López Gómez JM
Nefrologia; 2002; 22 Suppl 1():68-74. PubMed ID: 11987673
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress in chronic renal failure as a cardiovascular risk factor.
Siems W; Quast S; Carluccio F; Wiswedel I; Hirsch D; Augustin W; Hampi H; Riehle M; Sommerburg O
Clin Nephrol; 2002 Jul; 58 Suppl 1():S12-9. PubMed ID: 12227720
[TBL] [Abstract][Full Text] [Related]
18. Serum carboxymethyllysine predicts mortality in hemodialysis patients.
Wagner Z; Molnár M; Molnár GA; Tamaskó M; Laczy B; Wagner L; Csiky B; Heidland A; Nagy J; Wittmann I
Am J Kidney Dis; 2006 Feb; 47(2):294-300. PubMed ID: 16431258
[TBL] [Abstract][Full Text] [Related]
19. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
[TBL] [Abstract][Full Text] [Related]
20. Inflammation but not oxidative stress is associated with beta-chemokine levels and prevalence of cardiovascular disease in uraemic patients.
Pawlak K; Pawlak D; Myśliwiec M
Cytokine; 2006 Sep; 35(5-6):258-62. PubMed ID: 17070067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
